Skip to main content

Tweets

Lupus GPT - a chatbot which is much more relevant to Lupus - for patients and physician question etc. #EULAR2024 - Will be functional soon. Looking forward to playing with this. #LLMs #ChatGPT More to come. @RheumNow https://t.co/mGXG6A85Hx
Bella Mehta @bella_mehta ( View Tweet )
2 years ago
Biomarkers in Lupus - Urine biomarkers @andreafava in #EULAR2024 We need these biomarkers to come in mainstream clinical practice if they work better than proteinuria. @RheumNow https://t.co/i7aeBx6qRR
Bella Mehta @bella_mehta ( View Tweet )
2 years ago
@Lupusreference noted data suggests pulse IV methylprednisolone yields better outcomes for LN than adjustments of chronic oral steroids. #EULAR24 @RheumNow https://t.co/n93x036uIn
TheDaoIndex @KDAO2011 ( View Tweet )
2 years ago
Precision medicine in Lupus is far from reality today. @Lupusreference @RheumNow #EULAR2024

Bella Mehta @bella_mehta ( View Tweet )

2 years ago
Whats new in Lupus #EULAR2024 @Lupusreference lecture - many pearls. Corticosteroids IV may be the way to go - referencing @AliDuarteMD team (better outcomes compared to oral steroids) @RheumNow https://t.co/Fz1dZUVomF
Bella Mehta @bella_mehta ( View Tweet )
2 years ago
Should we treat to target (T2T) for #SLE or just do SOC and gestalt (as most do in clinical practice)? @Lupusreference #EULAR24 @RheumNow

TheDaoIndex @KDAO2011 ( View Tweet )

2 years ago
💊 Difficult-to-treat #SpA & #PsA 🤔 What are the challenges in assessing persistently active disease? 🗣️ Vinod Chandran takes us through the pearls and pitfalls in assessing D2T disease 🌎 Great to see #comorbidities highlighted @RheumNow #EULAR2024 https://t.co/x4jUTOC3li
Mrinalini Dey @DrMiniDey ( View Tweet )
2 years ago
Dr. G Schett reported using CAR-T cell Rx in patients w/ 1. pedi-SLE 2. CNS lupus 3. refractory cases with success. Post- Rx vaccine response is fine, infection risk is less since pts no longer need steroids. He is still following the pts for relapse and AEs @RheumNow #EULAR24

TheDaoIndex @KDAO2011 ( View Tweet )

2 years ago
Consider the source and type of pain when managing axSpA including nociplastic pain. Difficult to treat axSpA #EULAR2024 Rudwaleit M @RheumNow https://t.co/4rszIyw5V6
Dr. Antoni Chan @synovialjoints ( View Tweet )
2 years ago
CAR-T effective B cell depletion preserving plasma cell function @rheumnow #EULAR2024 https://t.co/mYmwC2cV6e
Peter Nash @drpnash ( View Tweet )
2 years ago
« CAR T cells can change the therapeutic scenario: a short treatment for a prolonged efficacy » says G. Schett Are we finally looking at the « visionary scenario »? @RheumNow #EULAR2024 https://t.co/tzfDormeIl
Aurelie Najm @AurelieRheumo ( View Tweet )
2 years ago
@Janetbirdope @RheumNow #EULAR2024 JAK-i Debate @drdavidliew (NOT in support of regulation) - is the signal real? Query about replicability & data came from N. America. Not reflected on real-world data of enriched cohorts - is the warning justified? - are there unintended consequences? @RheumNow https://t.co/TXUf90fqwN
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
2 years ago
×